pyruvaldehyde has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, NJR | 1 |
| Vulesevic, B | 1 |
| McNeill, B | 1 |
| Cimenci, CE | 1 |
| Ahmadi, A | 1 |
| Gonzalez-Gomez, M | 1 |
| Ostojic, A | 1 |
| Zhong, Z | 1 |
| Brownlee, M | 1 |
| Beisswenger, PJ | 1 |
| Milne, RW | 1 |
| Suuronen, EJ | 1 |
| Subramanian, U | 1 |
| Nagarajan, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Action of Glycation and Inflammation in Operative Ischemic Heart Disease[NCT05112731] | 60 participants (Anticipated) | Observational | 2022-02-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pyruvaldehyde and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Collagen Type I; Disease Models, Animal; Genetic Predisposition | 2017 |
All-Trans Retinoic Acid supplementation prevents cardiac fibrosis and cytokines induced by Methylglyoxal.
Topics: Animals; Cytokines; Dietary Supplements; Fibrosis; Gene Expression Regulation; Male; Pyruvaldehyde; | 2017 |